Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1990-8-2
|
pubmed:abstractText |
Amifloxacin pharmacokinetics after a single oral dose in healthy elderly subjects were determined. Five males and five females aged 65 to 79 years and having creatinine clearances of 39.3 to 87.2 ml/h per kg of body weight were given a 200-mg amifloxacin caplet following an overnight fast. Mean (standard deviation) pharmacokinetic parameters for amifloxacin were as follows: maximum observed concentration in plasma, 1.13 (0.48) and 1.95 (0.52) micrograms/ml; half-life, 5.37 (0.96) and 4.47 (0.87) h; total plasma clearance (unadjusted for fraction absorbed), 259 (53) and 199 (55) ml/h per kg; renal clearance, 113 (20) and 86 (26) ml/h per kg; Varea/F (Varea is volume of distribution; F is fraction absorbed), 2.05 (0.75) and 1.28 (0.39) liter/kg; and amifloxacin excreted in the urine, 42.5% (14.5%) and 42.8% (10.6%) for males and females, respectively. There were no statistically significant differences in pharmacokinetic parameters between sexes that could not be attributed to differences in body weight. Except for a modest 23% reduction in renal clearance and the suggestion of reduced bioavailability, mean values of pharmacokinetic parameters for elderly male subjects were similar to those previously determined for younger male volunteers. Therefore, a modification in amifloxacin dosage regimen based solely on age may not be necessary.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-2940518,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-3282749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-3480221,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-3659579,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-3939218,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-4064609,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-6381730,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-6517556,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2360815-6517559
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0066-4804
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
751-4
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2360815-Adult,
pubmed-meshheading:2360815-Aged,
pubmed-meshheading:2360815-Anti-Infective Agents,
pubmed-meshheading:2360815-Biological Availability,
pubmed-meshheading:2360815-Ciprofloxacin,
pubmed-meshheading:2360815-Female,
pubmed-meshheading:2360815-Fluoroquinolones,
pubmed-meshheading:2360815-Humans,
pubmed-meshheading:2360815-Male,
pubmed-meshheading:2360815-Spectrophotometry, Ultraviolet
|
pubmed:year |
1990
|
pubmed:articleTitle |
Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
|
pubmed:affiliation |
Sterling Research Group, Rensselaer, New York 12144.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|